127 results
Page 3 of 7
8-K
EX-99.1
fjv9w u99x
15 Aug 22
Equillium Reports Second Quarter 2022 Financial Results and Provides Clinical Development Updates
4:22pm
8-K
EX-99.1
6f336
12 May 22
Equillium Reports First Quarter 2022 Financial Results and Provides Corporate and Clinical Development Updates
4:07pm
8-K
qwdd1 dgnyxsw0jb
9 May 22
Other Events
8:06am
8-K
i6wiker h72
25 Apr 22
Other Events
8:05am
8-K
EX-99.1
yr1f5amj
23 Mar 22
Equillium Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate & Clinical Development Updates
4:05pm
8-K
EX-99.1
mq4sbehfpqjkn2e 8m5
4 Mar 22
Equillium Announces Initiation of the Phase 3 EQUATOR Study of Itolizumab in First-line Acute Graft-Versus-Host Disease
2:00pm
8-K
EX-99.1
a0jh 3r5sq0x3
2 Mar 22
Equillium Announces Appointment of Barbara Troupin to Board of Directors
9:00am
8-K
EX-2.1
o73v9gho0iiubz
16 Feb 22
Equillium Acquires Bioniz Therapeutics
7:01am
8-K
EX-99.1
xyj72dgw1tm az25
16 Feb 22
Equillium Acquires Bioniz Therapeutics
7:01am
8-K
EX-99.2
kcsskswpgsr4ykxjdfby
16 Feb 22
Equillium Acquires Bioniz Therapeutics
7:01am
8-K
EX-99.1
zo0j0ua
10 Nov 21
Equillium Reports Third Quarter 2021 Financial Results and Provides Clinical Development Updates
4:05pm
8-K
EX-99.1
rscem3
10 Aug 21
Equillium Reports Second Quarter 2021 Financial Results and Provides Clinical Development Update
4:11pm
8-K
EX-99.1
8kdz0 8jtydv
12 Jul 21
Regulation FD Disclosure
4:00pm
8-K
EX-99.1
6dsxfd7x 6d37
11 Jun 21
Equillium Announces Positive Topline Results from the EQUATE Study in First-line Treatment of Acute Graft-Versus-Host Disease
7:00am
8-K
EX-99.1
4525mcc9d6p13riwzxx
10 Jun 21
Regulation FD Disclosure
11:13am
8-K
EX-99.1
6lq0gp7x0vzz x0sj3
7 Jun 21
Regulation FD Disclosure
3:13pm